Abstract | OBJECTIVE: The purpose of this study was to identify how different degrees of cholesterol synthesis inhibition affect human hepatic cholesterol metabolism. METHODS AND RESULTS: CONCLUSIONS:
Statin treatment reduces ACAT2 activity in human liver and this effect, in combination with a reduced Apo E expression, may contribute to the favorable lowering of VLDL cholesterol seen in addition to the LDL lowering during statin treatment.
|
Authors | Paolo Parini, Ulf Gustafsson, Matt A Davis, Lilian Larsson, Curt Einarsson, Martha Wilson, Mats Rudling, Hiroshi Tomoda, Satoshi Omura, Staffan Sahlin, Bo Angelin, Lawrence L Rudel, Mats Eriksson |
Journal | Arteriosclerosis, thrombosis, and vascular biology
(Arterioscler Thromb Vasc Biol)
Vol. 28
Issue 6
Pg. 1200-6
(Jun 2008)
ISSN: 1524-4636 [Electronic] United States |
PMID | 18340009
(Publication Type: Journal Article, Randomized Controlled Trial, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Apolipoproteins E
- Cholesterol, VLDL
- Fatty Acids, Monounsaturated
- Heptanoic Acids
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Indoles
- Pyrroles
- RNA, Messenger
- Receptors, LDL
- Fluvastatin
- lathosterol
- Cholesterol
- Atorvastatin
- Hydroxymethylglutaryl CoA Reductases
- Sterol O-Acyltransferase
|
Topics |
- Apolipoproteins E
(metabolism)
- Atorvastatin
- Biopsy
- Cholesterol
(blood, metabolism)
- Cholesterol, VLDL
(metabolism)
- Fatty Acids, Monounsaturated
(pharmacology)
- Female
- Fluvastatin
- Heptanoic Acids
(pharmacology)
- Humans
- Hydroxymethylglutaryl CoA Reductases
(metabolism)
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
(pharmacology)
- Indoles
(pharmacology)
- Liver
(drug effects, metabolism, pathology)
- Male
- Middle Aged
- Pyrroles
(pharmacology)
- RNA, Messenger
(metabolism)
- Receptors, LDL
(metabolism)
- Sterol O-Acyltransferase
(drug effects, metabolism)
- Sterol O-Acyltransferase 2
|